What it is

ERR agonist studied as an exercise-mimetic in metabolic and aging-adjacent literature.

Also known as

ERR agonist · Exercise-mimetic research compound · SLU-PP-332

Overview

SLU-PP-332 is a small-molecule estrogen-related receptor (ERR) agonist studied as an exercise-mimetic in metabolic and aging-adjacent literature. It is listed beside mitochondrial and metabolic research tools on some peptide-adjacent catalogs.

Research interest is ERR-driven oxidative metabolism and endurance-related endpoints in preclinical models. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• ERR-agonist metabolic and oxidative-phosphorylation endpoints

• • Exercise-mimetic endurance markers in preclinical models

• • Mitochondrial biogenesis–adjacent readouts where studied

• • Body-composition and energy-expenditure measures

• • Aging-adjacent metabolic pharmacology versus MDPs and AMPK tools

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early mitochondrial and energy-metabolism readouts; compound accumulating in model systems.

Week 3–4: Clearer redox, endurance, or cellular-energy markers in short preclinical windows.

Month 2–3: More pronounced metabolic and cytoprotection endpoints in extended designs.

Month 3–6: Sustained mitochondrial and aging-adjacent observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.